Back to Top Skip to main content

NMHM looks back at the 1918 ‘Spanish flu’ for one Maryland county

Black and white image of hospital beds lined up in rows, occupied by sick people Emergency hospital during influenza epidemic, Camp Funston, Kansas. (NCP 1603) (Photo by: NMHM.)

Recommended Content:

Coronavirus | Public Health

The year 1918 proved to be a trying time for people overseas and at home. Still in the midst of World War I, populations were then introduced to another adversary: the “Spanish Flu.” While great medical strides had been made to prevent other deadly diseases, such as smallpox, by the time of the global outbreak of influenza in 1918, the flu virus, or H1N1, had yet to be identified.

The 1918 flu resembled a more severe cold. The symptoms included fever, pains in the head and other body parts, and fatigue. While some patients recovered, others developed more severe and deadly conditions, like pneumonia or meningitis. Perhaps the greatest threat of the 1918 flu was the contagious nature of the virus with approximately one third of the world’s population infected and an estimated 50-100 million global fatalities.

During a virtual “science café” held by the National Museum of Health and Medicine (NMHM) last month, NMHM’s Historical Collections Manager Alan Hawk discussed the rapid spread of the 1918 influenza pandemic in a case study on Montgomery County, Maryland.

In 1918, Montgomery County was transitioning from a rural farming community into a suburban area. The county had recently improved its transportation systems connecting railroads and trolley lines to Washington, D.C. for those commuting to work in the city. Less than a month after the first influenza fatality in Washington, D.C., there was an estimated 1,200 cases of influenza in Montgomery County; most cases were within five miles of the railroad or trolley lines.

As we know today, the influenza virus is easily transmitted between those in close proximity to each other, up to about six feet, making the crowded trolleys and trains a prime place for spreading the flu in 1918. This was particularly damaging to the U.S. military, as traveling military personnel often shared cramped quarters in barracks, trains, and trenches.

The devastating impact of the flu in Montgomery County and the surrounding areas drove public health officials to require the adornment of gauze masks in public, and locals to cancel events with large gatherings of people.

While a vaccine wouldn’t be developed for a few more decades, military laboratories and civilian scientists worked tirelessly in 1918 to discover the agent that caused the flu. Autopsies were performed and samples of lung tissue were forwarded to the Army Medical Museum (now NMHM) for further study and preservation. 

Along with the tissue specimens, the museum collected archival and historical materials – for example, photographs showing influenza wards like Camp Funston, Kansas, a possible ground zero for the virus in America, and medical equipment – to illustrate the devastating impact of the 1918 pandemic and the military’s medical response. 

These materials aid today’s researchers in parsing history and understanding the nature of the 1918 flu in comparison to current strains or other viruses. A virtual exhibit shows how DoD scientists used a sample of lung tissue to recreate the genetic sequence of the 1918 virus, and a new teacher’s guide compares the 1918 influenza to COVID-19. Perhaps future studies can help us identify key characteristics of the 1918 influenza pandemic and why it was so deadly.

For those interested in accessing the collections for research, visit the museum’s website.

You also may be interested in...

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Embedded Fragment Analyses

Policy

Clarification of the Requirement for Continuation of Semi-Annual Reporting of Results of Embedded Fragment Analyses

Influenza Surveillance Program

Policy

Sentinel Sites for the 2014-2015 Influenza Surveillance Program

Deployment Limiting Mental Disorders and Psychotrophic Medications

Policy

Policy memorandum about Deployment Limiting Mental Disorders and Psychotrophic Medications

Access to Medical Services Who were Exposed to Rabies in Combat Theater

Policy

U.S. Navy/U.S. Marine Corps COSC Policy Update

Policy

Mental Health Assessments for Members of the Armed Forces Deployed in Connection with a Contingency Operation

Policy

Clinical Policy for the Administration of the Anthrax Vaccine Adsorbed

Policy
<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.